NAGY KHEIR: Open Payments
NPI 1518900661 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$732 in 41 payments from 8 companies in 2025. Trend: 2023 $569 · 2024 $942 · 2025 $732
Food & beverage: $732
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $166 |
| ABBVIE INC. | 11 | $162 |
| Luye Pharma (USA) Ltd. | 6 | $114 |
| Otsuka America Pharmaceutical, Inc. | 4 | $110 |
| Janssen Pharmaceuticals, Inc | 3 | $63 |
| Noven Therapeutics, LLC | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Alkermes, Inc. | 1 | $16 |
Products named: COBENFY, VRAYLAR, ERZOFRI EXTENDED-RELEASE, REXULTI, INVEGA SUSTENNA, Xelstrym, Auvelity, ABILIFY ASIMTUFII.
Industry payments across MI — which companies pay providers there.
